Kerala Ayurveda Stock Screener | Share Price & Fundamental Analysis
KERALAYUR
Pharmaceuticals
Share Price BSE
₹218.90
▼
-1.85 (-0.84%)
As of April 29, 2026, the Kerala Ayurveda share price (BSE: KERALAYUR) is ₹218.90, down 0.84% from the previous close, with shares trading between ₹216.10 and ₹222.95, and a 52-week range of ₹157.75–₹603.95.
Browse KERALAYUR financial statements to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Kerala Ayurveda Market Cap
₹297.55 Cr.
KERALAYUR P/E Ratio (TTM)
-12.27
Kerala Ayurveda P/B Ratio
11.29
EPS (TTM)
₹-11.60
Dividend Yield
-
Debt to Equity
5.21
KERALAYUR 52 Week High
₹603.95
Kerala Ayurveda 52 Week Low
₹157.75
Operating Margin
-32.00%
Profit Margin
-46.88%
KERALAYUR Revenue (TTM)
₹32.00
EBITDA
₹-9.00
Net Income
₹-15.00
Total Assets
₹129.00
Total Equity
₹13.00
Kerala Ayurveda Share Price History - Stock Screener Chart
Screen KERALAYUR historical share price movements with interactive charts. Analyze price trends and patterns.
Kerala Ayurveda Company Profile - Fundamental Screener
Screen Kerala Ayurveda company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for KERALAYUR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE817B01025
Kerala Ayurveda Balance Sheet Screener
Screen KERALAYUR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 129 | 133 | 115 | 110 | 115 | 103 | 92 | 103 | 81 | 73 |
| Current Assets | 41 | 56 | 34 | 37 | 44 | 33 | 28 | 42 | 22 | 14 |
| Fixed Assets | 47 | 41 | 46 | 44 | 33 | 33 | 33 | 33 | 34 | 34 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 28 | 28 | 55 | 42 | 67 | 63 | 59 | 48 | 24 | 54 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 13 | 21 | 8 | 8 | 5 | 10 | 5 | 10 | 9 | -5 |
| Share Capital | 12 | 12 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves & Surplus | -3 | 7 | -5 | -4 | -7 | -3 | -7 | -3 | -4 | -17 |
Kerala Ayurveda Income Statement Screener - Profit & Revenue Analysis
Screen Kerala Ayurveda income statement and profit fundamentals.
Analyze KERALAYUR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Kerala Ayurveda share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32 | 38 | 37 | 34 | 32 | 28 | 31 | 31 | 24 | 24 | 26 | 27 | 21 | 19 | 24 |
| Expenses | 42 | 33 | 40 | 35 | 27 | 27 | 25 | 32 | 23 | 22 | 25 | 25 | 19 | 18 | 22 |
| EBITDA | -9 | 5 | -3 | 0 | 5 | 1 | 6 | -1 | 1 | 2 | 1 | 1 | 2 | 1 | 3 |
| Operating Profit % | -32.00% | -15.00% | -14.00% | -5.00% | 15.00% | 3.00% | 18.00% | -4.00% | 3.00% | 6.00% | 2.00% | 4.00% | 10.00% | 3.00% | 9.00% |
| Depreciation | 2 | 2 | 1 | 1 | 1 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 3 | 1 | 3 | 3 | 3 | 1 | 1 | 0 | 1 | 2 | 1 | 1 | 2 | 1 | 1 |
| Profit Before Tax | -14 | 3 | -7 | -4 | 0 | 0 | 4 | -2 | -1 | 0 | 0 | 0 | 0 | -1 | 1 |
| Tax | 2 | 1 | -1 | 0 | 0 | 0 | 0 | 1 | -1 | 0 | 0 | 1 | 0 | 0 | 0 |
| Net Profit | -15 | 2 | -6 | -5 | 1 | 1 | 4 | -3 | 1 | 0 | 0 | -1 | 0 | -1 | 1 |
| EPS | -13.68 | 1.92 | -7.23 | -3.69 | 0.50 | 0.33 | 3.10 | -2.40 | 0.24 | -3.24 | 0.07 | -0.84 | 0.06 | -0.77 | 0.98 |
Kerala Ayurveda Cash Flow Screener - Liquidity Fundamentals
Screen KERALAYUR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 5 | -1 | 10 | -1 | 7 | 5 | 12 | -10 | 4 | 6 |
| Investing Activities | -15 | 0 | -7 | -2 | -1 | -4 | -3 | -3 | -3 | -3 |
| Financing Activities | -10 | 20 | -1 | -13 | 6 | 1 | -12 | 17 | 0 | -2 |
| Net Cash Flow | -19 | 18 | 2 | -16 | 12 | 2 | -2 | 4 | 1 | 0 |
Kerala Ayurveda Shareholding Pattern Screener
See Kerala Ayurveda shareholding pattern with promoter, FII, and DII holdings.
Check Kerala Ayurveda promoter holding and ownership changes for KERALAYUR on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Jan | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 35.61% | 58.58% | 37.83% | 33.14% | 33.14% | 58.58% | 58.58% | 58.58% |
| FII Holding | 0.17% | 0.00% | 0.00% | 0.00% | 0.22% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 42.16% | 32.23% | 41.26% | 44.36% | 44.42% | 31.71% | 31.58% | 32.25% |
| Other Holding | 22.03% | 9.15% | 20.87% | 22.46% | 22.18% | 9.67% | 9.80% | 9.13% |
| Shareholder Count | 10,184 | 9,074 | 9,401 | 9,938 | 9,952 | 8,552 | 8,581 | 8,655 |
Kerala Ayurveda Share Dividend Screener - Share Yield Analysis
Check Kerala Ayurveda dividend history with payout and yield data.
View Kerala Ayurveda dividend details including ex-dates and amounts for KERALAYUR stock.
Kerala Ayurveda Stock Index Membership
See which indices include Kerala Ayurveda stock.
Check KERALAYUR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Kerala Ayurveda Market Events Screener - Corporate Actions
Get Kerala Ayurveda corporate actions including splits, bonuses, and buybacks.
Check Kerala Ayurveda stock events that may affect KERALAYUR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.67% | ||
| Annual General Meeting | NA | -6.82% | ||
| 2026-03-14 | 2026-03-14 | Extraordinary General Meeting | NA | -30.44% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | -1.04% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -2.13% |
| 2025-07-18 | 2025-07-18 | Quarterly Result Announcement | NA | -0.01% |
| 2025-06-18 | 2025-06-18 | Extraordinary General Meeting | NA | 16.59% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | -7.92% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -4.92% |
| 2025-01-03 | 2025-01-03 | Extraordinary General Meeting | NA | 19.17% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -4.46% |
| 2023-12-20 | 2023-12-20 | Extraordinary General Meeting | NA | 6.04% |
Kerala Ayurveda Competitors Screener - Peer Comparison
Screen KERALAYUR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 415,925 | 35.49 | 54,729 | 9.71% | 10,980 | 54.07 |
| Divis Laboratories | 171,944 | 68.10 | 9,712 | 18.67% | 2,191 | 68.17 |
| Torrent Pharmaceuticals | 142,817 | 61.31 | 11,539 | 6.99% | 1,911 | 54.09 |
| Dr Reddys Laboratories | 111,383 | 19.89 | 33,741 | 16.73% | 5,725 | 64.26 |
| Cipla | 106,401 | 23.07 | 28,410 | 7.12% | 5,291 | 64.71 |
| Lupin | 106,240 | 22.48 | 22,910 | 13.74% | 3,306 | 53.12 |
| Zydus Life Science | 94,551 | 18.56 | 23,511 | 18.55% | 4,615 | 58.75 |
| Mankind Pharma | 93,653 | 51.90 | 12,744 | 20.90% | 2,007 | 67.97 |
| Aurobindo Pharma | 82,282 | 23.56 | 32,346 | 9.43% | 3,484 | 67.39 |
| Glenmark Pharmaceuticals | 65,615 | 60.89 | 13,436 | 6.18% | 1,047 | 65.50 |
Kerala Ayurveda Company Announcements - News Screener
Screen KERALAYUR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - | |
| 2026-04-16 | Announcement Under Regulation 30 (LODR) | - |
| 2026-04-08 | Clarification On Price Movement | - |
| 2026-04-08 | Clarification sought from Kerala Ayurveda Ltd | - |
| 2026-04-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-03-25 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-03-21 | Board Meeting Intimation for The Proposal For Fund Raising By Way Of Issue Of Unlisted Secured Redeemable Non-Convertible Debentures For A Value Upto Rs. 40 Crores To Be Held On 25 March 2026. | - |
| 2026-03-21 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-03-14 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-03-14 | Shareholder Meeting / Postal Ballot-Outcome of EGM | - |
| 2026-02-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-19 | Extraordinary General Meeting Of Kerala Ayurveda Limited | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Preferential Issue | - |
| 2026-02-12 | Pursuant To Regulation 30 Read With Schedule III Of SEBI (Listing Obligations And Dislcosure Requirements) Regulations 2015 We Wish To Inform That The Nomination And Remuneration Committee Of The Board Of Directors Of Kerala Ayurveda Limited Has Approved | - |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-02-12 | Financial Results For The Quarter Ended 31St December2025 | - |
| 2026-02-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th February 2026 | - |